1. Home
  2. SA vs ICUI Comparison

SA vs ICUI Comparison

Compare SA & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seabridge Gold Inc. (Canada)

SA

Seabridge Gold Inc. (Canada)

HOLD

Current Price

$33.43

Market Cap

3.7B

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$132.23

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SA
ICUI
Founded
1979
1984
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.9B
IPO Year
2004
1995

Fundamental Metrics

Financial Performance
Metric
SA
ICUI
Price
$33.43
$132.23
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
$65.00
$182.25
AVG Volume (30 Days)
840.0K
262.1K
Earning Date
01-01-0001
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
100.62
EPS
N/A
0.03
Revenue
N/A
$2,231,262,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.10
P/E Ratio
N/A
$4,574.00
Revenue Growth
N/A
N/A
52 Week Low
$9.40
$107.02
52 Week High
$40.06
$160.29

Technical Indicators

Market Signals
Indicator
SA
ICUI
Relative Strength Index (RSI) 46.97 31.28
Support Level $28.46 $125.04
Resistance Level N/A $136.39
Average True Range (ATR) 1.86 6.40
MACD -0.39 -1.98
Stochastic Oscillator 29.53 9.83

Price Performance

Historical Comparison
SA
ICUI

About SA Seabridge Gold Inc. (Canada)

Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: